Advanced search
Start date
Betweenand


Continuous flow reactions in the preparation of active pharmaceutical ingredients and fine chemicals

Full text
Author(s):
Martins, Guilherme M. ; Braga, Felipe C. ; de Castro, Pedro P. ; Brocksom, Timothy J. ; de Oliveira, Kleber T.
Total Authors: 5
Document type: Journal article
Source: CHEMICAL COMMUNICATIONS; v. 60, n. 24, p. 14-pg., 2024-02-29.
Abstract

Herein, we present an overview of continuous flow chemistry, including photoflow and electroflow technologies in the preparation of active pharmaceutical ingredients (APIs) and fine chemical intermediates. Examples highlighting the benefits and challenges associated with continuous flow processes, mainly involving continuous thermal, photo- and electrochemical transformations, are drawn from the relevant literature, especially our experience and collaborations in this area, with emphasis on the synthesis and prospective scale-up. This feature article presents an overview of continuous flow chemistry, including photoflow and electroflow technologies in the preparation of active pharmaceutical ingredients (APIs) and fine chemical intermediates. (AU)

FAPESP's process: 23/04020-8 - APIs synthesis using enabling technologies: approaches involving electrosynthesis and photocatalysis under continuous flow conditions
Grantee:Kleber Thiago de Oliveira
Support Opportunities: Regular Research Grants
FAPESP's process: 22/00074-3 - Regioselective fluorination of N-heterocycles using electrosynthesis and continuous flow conditions
Grantee:Guilherme Ariel Machado Martins
Support Opportunities: Scholarships in Brazil - Post-Doctoral
FAPESP's process: 21/06110-9 - Application of continuous flow chemistry in the synthesis of Active Pharmaceutical Ingredients (APIs): cannabidiol, fentanyl, and ibuprofen
Grantee:Felipe Camargo Braga
Support Opportunities: Scholarships in Brazil - Post-Doctoral
FAPESP's process: 21/13924-2 - Development of novel continuous flow approaches towards the preparation of pharmaceuticals: Axitinib, Lacosamide, Pioglitazone and Rosiglitazone
Grantee:Pedro Pôssa de Castro
Support Opportunities: Scholarships in Brazil - Post-Doctoral